Insulin Degludec (R Dna Origin) 1 Ml Solution Contains 100 I.U (Eq. 3.66 Mg) In Prefilled Pen Of 3 Ml .

Tender Details

Particulars	Details
Title	Insulin Degludec (R Dna Origin) 1 Ml Solution Contains 100 I.U (Eq. 3.66 Mg) In Prefilled Pen Of 3 Ml .
Description	For Complete Deion And Other Details, Please Refer To Tender
Organisation	Ministry of Railways \| Central Govt. Ministry/Department
Tender Id	106391008
Reference Number	11245341A
Tender Fee	0
EMD	0
Tender Value	-
Place	Varanasi
Link	View Original Tender Notice https://www.ireps.gov.in/ireps/supply/pdfdocs/072024/106391008/viewNitPdf_4623147.pdf
Start Date	June 28, 2024 17:15
End Date	Expired 09/07/2024 Expired 832 days ago Search Similar tenders?

Tender Support

Get help with filing, GeM registration, documents, or relevant tender alerts.

Request filing assistance Opportunity Matching GeM Registration How to file this tender? WhatsApp Support Join WhatsApp Channel

Similar Tenders

Insulin degludec (r-dna origin)100iu/ml in 3ml penfills

Inj. insulin degludec 100 i.u.

Cartr insulin - human regular insulin r dna origin 100iu/ml -3ml

Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen

Insuline degludec inj 100iu/ml prefilled pen

Biphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin

Inj. insulin degludec 100 iu/ml, 3ml cartridge

Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

(ph no.:10013) human insulin mix.of 30/70 (rdna origin) 40 iu/ml - 10 ml inj.

Click Here to Download Dockets
of your Industry type

Tender Details

Tender Support

Insulin degludec (r-dna origin)100iu/ml in 3ml penfills

Inj. insulin degludec 100 i.u.

Cartr insulin - human regular insulin r dna origin 100iu/ml -3ml

Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen

Insuline degludec inj 100iu/ml prefilled pen

Biphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin

Inj. insulin degludec 100 iu/ml, 3ml cartridge

Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

(ph no.:10013) human insulin mix.of 30/70 (rdna origin) 40 iu/ml - 10 ml inj.

Get customized tender Recommendations for your Enterprise